Gilead commits to own development of coronavirus treatment hopeful

Gilead on Wednesday launched two late-stage studies of its experimental antiviral remdesivir as a potential treatment for the new coronavirus, throwing its own clinical development muscle into a now global effort to test whether the drug is effective in easing infection symptoms.